Bayer to pay $80.9M in Roundup cancer trial

Bayer to pay $80.9M in Roundup cancer trial
Image Credit: Flickr
  • Country:
  • United States

A U.S. jury on Wednesday awarded $80.9 million to a man who claimed his use of Bayer AG's glyphosate-based weed killer Roundup caused his cancer, in the latest legal setback for the company facing thousands of similar lawsuits.

The jury in San Francisco federal court said the company was liable for plaintiff Edwin Hardeman's non-Hodgkin's lymphoma.

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.